Biotricity, Inc. (BTCY)

Biotricity Income Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	12.06	12.06	9.64	7.65	3.38	1.42
Revenue Growth (YoY)	25.15%	25.15%	26.00%	126.02%	138.75%	256.03%
Cost of Revenue	3.71	3.71	4.2	3.08	2.11	0.93
Gross Profit	8.36	8.36	5.44	4.57	1.27	0.49
Selling, General & Admin	14.61	14.61	17.62	18.56	12.57	10.05
Research & Development	2.57	2.57	3.23	2.74	2.06	1.36
Operating Expenses	17.18	17.18	20.85	21.31	14.62	11.42
Operating Income	-8.83	-8.83	-15.41	-16.74	-13.35	-10.93
Interest Expense / Income	3.02	3.02	1.84	1.28	0	0
Other Expense / Income	2.25	2.25	1.41	11.11	2.14	0.14
Pretax Income	-14.09	-14.09	-18.66	-29.13	-15.49	-11.07
Net Income	-14.09	-14.09	-18.66	-29.13	-15.49	-11.07
Preferred Dividends	0.83	0.83	0.88	1.09	0.96	0.26
Net Income Common	-14.93	-14.93	-19.53	-30.22	-16.45	-11.32
Shares Outstanding (Basic)	9	9	9	8	6	6
Shares Outstanding (Diluted)	9	9	9	8	6	6
Shares Change	3.83%	3.83%	14.32%	21.13%	4.36%	7.73%
EPS (Basic)	-1.66	-1.66	-2.26	-3.99	-2.63	-1.89
EPS (Diluted)	-1.66	-1.66	-2.26	-3.99	-2.63	-1.89
Free Cash Flow	-6.69	-6.69	-13.55	-15.19	-11.08	-7.86
Free Cash Flow Per Share	-0.74	-0.74	-1.56	-2.01	-1.77	-1.31
Gross Margin	69.27%	69.27%	56.46%	59.74%	37.60%	34.26%
Operating Margin	-73.18%	-73.18%	-159.87%	-218.77%	-394.47%	-771.00%
Profit Margin	-123.75%	-123.75%	-202.65%	-395.01%	-486.10%	-798.81%
Free Cash Flow Margin	-55.49%	-55.49%	-140.55%	-198.60%	-327.37%	-554.61%
EBITDA	-10.7	-10.7	-16.47	-27.76	-15.49	-11.07
EBITDA Margin	-88.73%	-88.73%	-170.90%	-362.82%	-457.67%	-780.61%
Depreciation & Amortization	0.37	0.37	0.35	0.09	0	0
EBIT	-11.08	-11.08	-16.82	-27.85	-15.49	-11.07
EBIT Margin	-91.81%	-91.81%	-174.49%	-364.00%	-457.67%	-780.61%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).